beta-alanine has been researched along with everolimus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beerli, C; Brinkmann, V; Bruns, C; Cannet, C; Chen, A; Chu, A; Cooke, N; Gao, W; Gray, N; Guerini, D; Hinterding, K; Lefebvre, S; Liu, Y; Mi, Y; Nuesslein-Hildesheim, B; Pally, C; Pan, S; Streiff, M; Tuntland, T | 1 |
1 other study(ies) available for beta-alanine and everolimus
| Article | Year |
|---|---|
A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model.
Topics: Animals; beta-Alanine; CHO Cells; Cricetinae; Cricetulus; Everolimus; Extracellular Signal-Regulated MAP Kinases; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphocytes; Male; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred Lew; Receptors, Lysosphingolipid; Sirolimus; Thiophenes; Transplantation, Homologous | 2006 |